Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Comment by MBAon Dec 20, 2019 12:20pm
753 Views
Post# 30477109

RE:RE:Two Year Trend - Very Positive and Reflective Of Growth

RE:RE:Two Year Trend - Very Positive and Reflective Of GrowthI have no idea what that Best To Be .... is saying and don't care as he is on IGNORE. However, I do like your chart as it clearly shows the valuation of VMD can and did increase substantially in spite of the CB threat. The chart also clearly shows the investor reaction to the last two quarters. IMO, management should of communicated or provided better guidance on EBITDA impacts when they were so aggressively making investments into the company's future prospects. Investments like this and their impact are expected for visionary companies and investors wouldn't of reacted so negatively had management provided different guidance. In the end, I do think Casey is a fast learner and he will adjust his decisions accordingly in the future. The company should end 2019 with a run rate of about $110 million US and I expect the company will be north of $130 million at the end of 2020. At that point, many expect an impact of the competitive bidding pricing however, VMD will have had some time to grow into a larger company and have some time to spread its fixed costs across a larger revenue base. As a long term investor, I care about where the company is headed over the longer term, not the day to day, week to week or month to month variations in price.
Bullboard Posts